InvestorsHub Logo
Followers 4
Posts 851
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Friday, 03/29/2019 9:50:51 AM

Friday, March 29, 2019 9:50:51 AM

Post# of 1702
Key Takeaways include the following:

Cannabix has lost money every single year since inception (Over $6.7 Million total)

Each year Cannabix adds over 10 Million shares outstanding - diluting current shareholders

There has never been a sale or source of revenue since going public

Money going into R & D has never been over a Million $/year

EPS has always been negative and that will most likely be the case for 2019

Now let's compare to Lifeloc:

Lifeloc has made money every year since inception - (Over $43 Million since 2014)

Lifeloc has had sales/revenue of $8 Million or more every single year since 2014

Lifeloc has over $1 Million/year going into R & D efforts since 2014

Lifeloc has never diluted current shareholders - This is amazing. There are only a handful of companies that can say that.

Lifeloc has has positive EPS every year since becoming a public company

And recall that the preliminary work being done on the SpixDx technology began way before Cannabix even became a public company.

Bottom line - Lifeloc deserves to be valued at minimum to that of BLOZF

$45/Share - First price target.

This side by side comparison should put everything into perspective.

In my personal opinion, after doing this comparison I believe LCTC should trade at a 2-5 x multiple to that of BLOZF.

Let me know your thoughts/opinions on these findings.

Thanks and all the best!







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News